Effectiveness of reporting on latent tuberculous infection in Massachusetts, 2006-2008

被引：3
作者：
Hochberg, N. S. [1 ,2 ]
Kubiak, R. W. [1 ]
Tibbs, A. [3 ]
Elder, H. [1 ]
Sharnprapai, S. [3 ]
Etkind, S. [3 ]
Horsburgh, C. R., Jr. [1 ]
机构：
[1] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Infect Dis Sect, Boston, MA 02118 USA
[3] Massachusetts Dept Publ Hlth, Boston, MA 02118 USA
来源：
PUBLIC HEALTH ACTION | 2014年 / 4卷 / 01期
关键词：
surveillance; tuberculin test; interferon-gamma release test; epidemiology;
D O I：
10.5588/pha.13.0085
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Massachusetts is one of five states that mandate the reporting of latent tuberculous infection (LTBI). We assessed 2006-2008 Massachusetts surveillance data for LTBI to describe the system and examine the characteristics of persons with LTBI. Over 3 years, 15 301 LTBI cases were reported (4742-5398/year). Among those with known country of birth (n = 11 655), 9983 (85.7%) were foreign-born. Substantial under-ascertainment and/or under-reporting appear likely; mandatory reporting does not appear sufficient for LTBI detection. Enhanced targeted testing, active LTBI surveillance, or laboratory-based surveillance may be needed to eliminate tuberculosis disease in the United States.
引用
收藏
页码：53 / 55
页数：3
相关论文
共 9 条
  • [1] Prevalence of tuberculosis infection in the United States population - The National Health and Nutrition Examination Survey, 1999-2000
    Bennett, Diane E.
    Courval, Jeanne M.
    Onorato, Ida
    Agerton, Tracy
    Gibson, Judy D.
    Lambert, Lauren
    McQuillan, Geraldine M.
    Lewis, Brenda
    Navin, Thomas R.
    Castro, Kenneth G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) : 348 - 355
  • [2] Centers for Disease Control and Prevention, 2011, REP TUB US 2010
  • [3] Centers for Disease Control and Prevention, 2013, LAT TUB INF GUID PRI
  • [4] Priorities for the treatment of latent tuberculosis infection in the United States
    Horsburgh, CR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20) : 2060 - 2067
  • [5] Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States
    Linas, Benjamin P.
    Wong, Angela Y.
    Freedberg, Kenneth A.
    Horsburgh, C. Robert, Jr.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (05) : 590 - 601
  • [6] Medical Advisory Committee for the Elimination of Tuberculosis (MACET), 2009, LAT TUB INF GUID MAS
  • [7] Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup
    Shea, Kimberly M.
    Kammerer, J. Steve
    Winston, Carla A.
    Navin, Thomas R.
    Horsburgh, C. Robert, Jr.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2014, 179 (02) : 216 - 225
  • [8] Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Sterling, Timothy R.
    Villarino, M. Elsa
    Borisov, Andrey S.
    Shang, Nong
    Gordin, Fred
    Bliven-Sizemore, Erin
    Hackman, Judith
    Hamilton, Carol Dukes
    Menzies, Dick
    Kerrigan, Amy
    Weis, Stephen E.
    Weiner, Marc
    Wing, Diane
    Conde, Marcus B.
    Bozeman, Lorna
    Horsburgh, C. Robert, Jr.
    Chaisson, Richard E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23) : 2155 - 2166
  • [9] United States Census Bureau, 2004, POP PROJ STAT INT PO
1